An Open Study To Estimate The Plasma Pharmacokinetics Of PF-04764793 Administered Via Oral Inhalation Using Dry Powder Inhalers.

Trial Profile

An Open Study To Estimate The Plasma Pharmacokinetics Of PF-04764793 Administered Via Oral Inhalation Using Dry Powder Inhalers.

Completed
Phase of Trial: Phase I

Latest Information Update: 12 Feb 2010

At a glance

  • Drugs PF 4764793 (Primary)
  • Indications Obstructive airway disorders
  • Focus Pharmacokinetics
  • Most Recent Events

    • 12 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 10 Nov 2009 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 29 Sep 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top